Pediatric Patient Transfer to Adult Service:Transition Program Clinical Trial
— EVATRANSENDOfficial title:
Non-randomized Experimental Study Evaluating the Impact of Implantation of a New Organization in the Adult Sector Intended to Improve the Transition of Young People With Endocrine or Metabolic Diseases
| Verified date | February 2021 |
| Source | Assistance Publique - Hôpitaux de Paris |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
"Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital. The main objective of the study is to compare the rate of patients lost to follow-up at 24 months after the transfer of pediatrics between the Transend group and the (historical) control group.
| Status | Completed |
| Enrollment | 202 |
| Est. completion date | October 10, 2020 |
| Est. primary completion date | October 10, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 32 Years |
| Eligibility | Inclusion Criteria: - Patient aged 18 to 32 - Patient with endocrine or metabolic disease - Patient who had a follow-up in a pediatric department for his endocrine or metabolic disease - Patient transferred to the adult sector in the endocrinology, metabolism or nutrition department of Pitié-Salpêtrière - Patient who had a first post-transfer consultation between January 1, 2015 and September 1, 2017 - Patient with a social security protection Exclusion Criteria: - Patient who transferred to another adult service before being followed at Pitié-Salpêtrière - Patient who has expressed his opposition to participate in this research |
| Country | Name | City | State |
|---|---|---|---|
| France | Chef du Service d'Endocrinologie et Médecine de le Reproduction, Hôpital de la Pitié-Salpêtrière | Paris |
| Lead Sponsor | Collaborator |
|---|---|
| Assistance Publique - Hôpitaux de Paris |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Rate of patients lost to follow-up at 24 months post transfert | Defined by pathology as patients who have not been seen in a medical consultation since a time superior of the recommendation for his state of Heath at 24 months post-transfer and for whom no elements confirm a next consultation in the center nor a follow-up in another center | 24 months post transfert | |
| Secondary | Number of consultations not honored by the patient | Experimental group: patients transferred to adult service according to the Transend transition program (between September 2016 and January 2018) Control group: patients transferred to adult service without a transition program, in the same center, before the implementation of Traansend (between January 2015 and September 2016) | 24 to 36 months post transfert | |
| Secondary | Relationship of trust between caregiver and patient | Score calculated by wake Forest scaleis a validated scale of 10 items for the evaluation of the different components of trust.including 3 items on loyalty, 3 items on competence, 1 item on honesty and 3 items on global trust.
(short version) resulting from an evaluation anonymously made by patients |
24 to 36 months post transfert | |
| Secondary | Time to first consultation in adult medicine | Experimental group: patients transferred to adult service according to the Transend transition program (between September 2016 and January 2018) Control group: patients transferred to adult service without a transition program, in the same center, before the implementation of Traansend (between January 2015 and September 2016) | 24 to 36 months post transfert | |
| Secondary | Patient satisfaction | Satisfaction collected on a scale of 0 to 10 where 0 means the worst transfer imaginable resulting an anonymous assessment carried out by the Patients | 24 to 36 months post transfet | |
| Secondary | Avoided care consumption and associated costs | Costs associated with hospital emergency room visits, home visit of SOS doctor, unplanned hospitalization | 24 to 36 months post transfret | |
| Secondary | Compare the experience of the transition betmeen the two Groups | Frequency of feeling broken, continuity, need to contact the paediatrician, attention and perceived availability on the part of professionals on arrival in the adult hospital | 24 to 36 months post transfret | |
| Secondary | Assess Transend's efficiency | Cost/incremental cost-effectiveness ratio in cost gained and cost per loss of view | 24 to 36 months post transfret |